Didn't Lechrone state at the SHM that it's all about the re-exam right now - and that companies are reluctant to pay anything without that re-exam result? Why would any company pay anything right now - especially in this economy -if there's a chance the USPTO could come out and state that the patents failed the re-exam?
I believe the pending USPTO re-exams are the reason for the dwindled signings.